Meprobamate and Pulmonary oedema - a phase IV clinical study of FDA data
Pulmonary oedema is found among people who take Meprobamate, especially for people who are male, 20-29 old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Meprobamate and have Pulmonary oedema. It is created by eHealthMe based on reports of 2,189 people who have side effects when taking Meprobamate from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
2,189 people reported to have side effects when taking Meprobamate.
Among them, 101 people (4.61%) have Pulmonary oedema.
What is Meprobamate?
Meprobamate has active ingredients of meprobamate. It is often used in stress and anxiety. eHealthMe is studying from 2,149 Meprobamate users for its effectiveness, alternative drugs and more.
What is Pulmonary oedema?
Pulmonary oedema (fluid accumulation in the lungs) is found to be associated with 2,305 drugs and 1,845 conditions by eHealthMe.
Number of Meprobamate and Pulmonary oedema reports submitted per year:
Time on Meprobamate when people have Pulmonary oedema *:
Gender of people who have Pulmonary oedema when taking Meprobamate*:
Age of people who have Pulmonary oedema when taking Meprobamate *:
Common drugs people take besides Meprobamate *:
Common side effects people have besides Pulmonary oedema *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Meprobamate and have Pulmonary oedema?Check whether Pulmonary oedema is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Pulmonary oedema and when was it recovered:
Expand to all the drugs that have ingredients of meprobamate:
Alternative drugs to, pros and cons of Meprobamate:
- Meprobamate (2,149 reports)
Common Meprobamate side effects:
- Accidental overdose (therapeutic agent): 189 reports
- Cardiac arrest: 117 reports
- Completed suicide (act of taking one's own life): 195 reports
- Drug abuse and dependence: 228 reports
- Drug ineffective: 162 reports
- Drug toxicity: 175 reports
- Multiple drug overdose: 103 reports
- Overdose: 165 reports
- Pulmonary oedema (fluid accumulation in the lungs): 101 reports
Browse all side effects of Meprobamate:a b c d e f g h i j k l m n o p q r s t u v w x y z
Pulmonary oedema treatments and more:
- Pulmonary oedema (44,241 reports)
COVID vaccines that are related to Pulmonary oedema:
- Pulmonary oedema in Moderna COVID Vaccine
- Pulmonary oedema in Pfizer BioNTech Covid Vaccine
- Pulmonary oedema in Johnson and Johnson Covid Vaccine
Common drugs associated with Pulmonary oedema:
All the drugs that are associated with Pulmonary oedema:
- Pulmonary oedema (2,305 drugs)
Common conditions associated with Pulmonary oedema:
All the conditions that are associated with Pulmonary oedema:
- Pulmonary oedema (1,845 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on meprobamate (the active ingredients of Meprobamate) and Meprobamate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Lorazepam and Contrast Media Allergy - 5 seconds ago
- Methergine and Confusional State - 6 seconds ago
- Roxicodone and Oxygen Saturation Decreased - 7 seconds ago
- Peg-Intron and Body Temperature Decreased - 22 seconds ago
- Humulin R and Acute Kidney Failure - 28 seconds ago
- Humulin R and Renal Failure - Acute - 28 seconds ago
- Tricor and Albuterol Sulfate And Ipratropium Bromide drug interaction - 40 seconds ago
- Nexium and Aspiration Tracheal Abnormal - 41 seconds ago
- Vitamin D3 and Uterine Disorder - 43 seconds ago
- Taxol and Tooth Disorder - 47 seconds ago